Wildcat DX, LLC Acquires Navis Clinical Laboratories, Inc.

LabGenomics USA LLC Acquires QDx Pathology

September 5, 2023

Healthcare Services

LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.

Nexelis Acquires GSK Vaccines Clinical Bioanalytical Laboratory (Marburg)

January 20, 2021

Biotechnology

Nexelis, a portfolio company of Ampersand Capital Partners, has signed an asset purchase agreement to acquire GSK's GCLP-certified clinical bioanalytical laboratory in Marburg, Germany. Approximately 80 scientists and analysts will transfer to Nexelis, which also entered a five-year strategic collaboration with GSK to continue supporting vaccine development while expanding Nexelis' assay development and high-throughput clinical testing capabilities in Europe.

Labcorp Acquires Toxikon Corporation

November 18, 2021

Healthcare Services

Labcorp has acquired Toxikon Corporation, a Bedford, Massachusetts-based contract research organization that provides nonclinical in vivo and in vitro testing for pharmaceutical, biotech and medical device clients. The acquisition expands Labcorp Drug Development's nonclinical testing capabilities and creates a strategic Boston-area footprint; Toxikon reported approximately $40 million in annual revenue and the deal closed in December 2021.

Curative Inc. Acquires KorvaLabs, Inc.

May 19, 2020

Healthcare Services

Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.

ACT Laboratories Acquires CDX Analytics

September 28, 2022

Healthcare Services

ACT Laboratories, Inc. has agreed to acquire CDX Analytics, LLC to expand its cannabis and hemp testing footprint into Massachusetts. ACT Labs — majority owned by Intrinsic Capital Partners — said the deal (subject to Massachusetts regulatory approval) will extend its multistate laboratory network and enhance capacity and scientific capabilities for local cultivators, processors and dispensaries.

Northlane Capital Partners Invests in United States Drug Testing Laboratories

January 13, 2025

Healthcare Services

Northlane Capital Partners has acquired United States Drug Testing Laboratories (USDTL), a Des Plaines, Illinois-based forensic toxicology laboratory, in a transaction in which NCP invested alongside USDTL's management and founders Veronica and Doug Lewis. NCP will partner with management to expand USDTL's niche forensic testing capabilities and has appointed Albert Berger as CEO to lead the company's next phase of growth.